VIRIDIAN THERAPEUTICS INC COM USD0.01VIRIDIAN THERAPEUTICS INC COM USD0.01VIRIDIAN THERAPEUTICS INC COM USD0.01

VIRIDIAN THERAPEUTICS INC COM USD0.01

No trades
See on Supercharts

0K1R fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include Cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma, and Remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

0K1R does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company